Cooperative DNA Binding with AP-1 Proteins Is Required for Transformation by EWS-Ets Fusion Proteins

REFERENCES

• Arvand, A., and C. T. Denny. 2001. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747–5754.
   PubMed Web of Science ®Google Scholar
• Arvand, A., S. M. Welford, M. A. Teitell, and C. T. Denny. 2001. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res. 61:5311–5317.
   PubMedGoogle Scholar
• Bartel, F. O., T. Higuchi, and D. D. Spyropoulos. 2000. Mouse models in the study of the Ets family of transcription factors. Oncogene 19:6443–6454.
   PubMed Web of Science ®Google Scholar
• Bosc, D. G., B. S. Goueli, and R. Janknecht. 2001. Her2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20:6215–6224.
   PubMed Web of Science ®Google Scholar
• Chen, L., J. N. Glover, P. G. Hogan, A. Rao, and S. C. Harrison. 1998. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392:42–48.
   PubMedGoogle Scholar
• Delattre, O., J. Zucman, B. Ploufastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162–165.
   PubMed Web of Science ®Google Scholar
• Deneen, B., H. Hamidi, and C. T. Denny. 2003. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 63:4268–4274.
   PubMedGoogle Scholar
• Escalante, C. R., A. L. Brass, J. M. Pongubala, E. Shatova, L. Shen, H. Singh, and A. Aggarwal. 2002. Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol. Cell 10:1097–1105.
   PubMed Web of Science ®Google Scholar
• Foos, G., J. J. Garcia-Ramirez, C. K. Galang, and C. A. Hauser. 1998. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J. Biol. Chem. 273:18871–18880.
   PubMedGoogle Scholar
• Fu, S., I. Bottoli, M. Goller, and P. K. Vogt. 1999. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc. Natl. Acad. Sci. USA 96:5716–5721.
   PubMedGoogle Scholar
• Garvie, C. W., J. Hagman, and C. Wolberger. 2001. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8:1267–1276.
   PubMed Web of Science ®Google Scholar
• Goetz, T. L., T.-L. Gu, N. A. Speck, and B. J. Graves. 2000. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor α2. Mol. Cell. Biol. 20:81–90.
   PubMed Web of Science ®Google Scholar
• Graves, B. J., and J. M. Petersen. 1998. Specificity within the ets family of transcription factors. Adv. Cancer Res. 75:1–55.
   PubMed Web of Science ®Google Scholar
• Hassler, M., and T. J. Richmond. 2001. The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex. EMBO J. 20:3018–3028.
   PubMedGoogle Scholar
• Hever, A., R. G. Oshima, and C. A. Hauser. 2003. Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro. Exp. Cell Res. 290:132–143.
   PubMedGoogle Scholar
• Hill, C. S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73:395–406.
   PubMed Web of Science ®Google Scholar
• Hollenhorst, P. C., D. A. Jones, and B. J. Graves. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32:5693–5702.
   PubMed Web of Science ®Google Scholar
• Janknecht, R. 1996. Analysis of the ERK-stimulated transcription factor ER81. Mol. Cell. Biol. 16:1550–1556.
   PubMedGoogle Scholar
• Johnson, I. M., H. J. Spence, J. N. Winnie, L. McGarry, J. K. Vass, L. Meagher, G. Stapleton, and B. W. Ozanne. 2000. Regulation of a multigenic expression programmed by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion. Oncogene 19:5348–5358.
   PubMedGoogle Scholar
• Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and M. C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355–5362.
   PubMedGoogle Scholar
• Louie, M. C., H. Q. Yang, A. H. Ma, W. Xu, J. X. Zou, H. J. Kung, and H. W. Chen. 2003. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc. Natl. Acad. Sci. USA 100:2226–2230.
   PubMedGoogle Scholar
• Mao, X., S. Miesfeldt, H. Yang, J. M. Leiden, and C. B. Thompson. 1994. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269:18216–18222.
   PubMed Web of Science ®Google Scholar
• May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Sunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. 1993. Ewing sarcoma 11:22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90:5752–5756.
   PubMed Web of Science ®Google Scholar
• McCarthy, S. A., D. Chen, B. S. Yang, J. J. Garcia Ramirez, H. Cherwinski, X. R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401–2412.
   PubMed Web of Science ®Google Scholar
• McGarry, L. C., J. N. Winnie, and B. W. Ozanne. 2004. Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. Oncogene 23:5284–5292.
   PubMed Web of Science ®Google Scholar
• Ordway, J. M., K. Williams, and T. Curran. 2004. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 23:3737–3748.
   PubMed Web of Science ®Google Scholar
• Peterson, B. R., L. J. Sun, and G. L. Verdine. 1996. A critical arginine residue mediates cooperativity in the contact interface between transcription factors NFAT and AP-1. Proc. Natl. Acad. Sci. USA 94:13671–13676.
   Google Scholar
• Pufall, M. A., and B. J. Graves. 2002. Autoinhibitory domains: modular effectors of cellular regulation. Annu. Rev. Cell Dev. Biol. 18:421–462.
   PubMedGoogle Scholar
• Pufall, M. A., G. M. Lee, M. L. Nelson, H. S. Kang, A. Velyvis, L. E. Kay, L. P. McIntosh, and B. J. Graves. 2005. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science 309:142–145.
   PubMed Web of Science ®Google Scholar
• Sprowles, A., and R. Wisdom. 2003. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling. Oncogene 22:498–506.
   PubMedGoogle Scholar
• Thompson, A. D., M. A. Teitell, A. Arvand, and C. T. Denny. 1999. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 18:5506–5513.
   PubMed Web of Science ®Google Scholar
• Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631–4640.
   PubMedGoogle Scholar
• Ullman, K. S., J. P. Northrop, A. Admon, and G. R. Crabtree. 1993. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Dev. 7:188–196.
   PubMedGoogle Scholar
• Wisdom, R., R. S. Johnson, and C. Moore. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188–197.
   PubMed Web of Science ®Google Scholar
• Wisdom, R., L. Huynh, D. Hsia, and S. Kim. 2005. Ras and TGF-b exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 24:7043–7054.
   PubMedGoogle Scholar
• Yang, B. S., C. A. Hauser, G. Henkel, M. S. Colman, C. van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538–547.
   PubMed Web of Science ®Google Scholar